ATRC AtriCure Inc

Price (delayed)

$43.49

Market cap

$2.21B

P/E Ratio

207.1

Dividend/share

N/A

EPS

$0.21

Enterprise value

$2.12B

?
Relative Growth: Rel. Growth: 79
Relative Strength: Rel. Strength: 85
Relative Valuation: Rel. Valuation: 24
Relative Profitability: Rel. Profitability: 68

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 59 million people worldwide. Electrophysiologists, cardiothoracic and thoracic surgeons around the globe use ...

Highlights
ATRC's net income has soared by 129% YoY
AtriCure's EPS has soared by 127% YoY

Key stats

What are the main financial stats of ATRC

ATRC stock price

How has the AtriCure stock price performed over time
Intraday
-0.16%
1 week
10.13%
1 month
24.97%
1 year
18.5%
YTD
9.93%
QTD
55.43%

Financial performance

How have AtriCure's revenue and profit performed over time
Revenue
$569.62M
Gross profit
$434.61M
Operating income
$12.89M
Net income
$10.55M
Gross margin
76.3%
Net margin
1.9%
The operating income has soared by 138% YoY
The operating margin has surged by 134% year-on-year
ATRC's net income has soared by 129% YoY
The net margin has soared by 126% YoY

Price vs fundamentals

How does ATRC's price correlate with its fundamentals

Growth

What is AtriCure's growth rate over time

Valuation

What is AtriCure stock price valuation
P/E
207.1
P/B
4.26
P/S
3.72
EV/EBIT
119.35
EV/EBITDA
54.83
EV/Sales
3.71
AtriCure's EPS has soared by 127% YoY
ATRC's price to book (P/B) is 29% higher than its last 4 quarters average of 3.3 and 3.9% higher than its 5-year quarterly average of 4.1
The equity has grown by 11% YoY and by 5% from the previous quarter
ATRC's P/S is 28% below its 5-year quarterly average of 5.2 but 28% above its last 4 quarters average of 2.9
ATRC's revenue is up by 14% year-on-year and by 3.2% since the previous quarter

Efficiency

How efficient is AtriCure business performance
The company's return on invested capital has surged by 160% YoY
AtriCure's ROS has soared by 153% YoY
The ROE has soared by 127% YoY
AtriCure's return on assets has surged by 127% YoY

Dividends

What is ATRC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ATRC.

Financial health

How did AtriCure financials performed over time
AtriCure's quick ratio has increased by 13% YoY
AtriCure's total assets has increased by 11% YoY and by 5% QoQ
The debt is 86% less than the equity
The debt to equity has declined by 18% year-on-year and by 7% since the previous quarter
The equity has grown by 11% YoY and by 5% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.